Immunovia AB (publ) (STO:IMMNOV)
Sweden · Delayed Price · Currency is SEK 0.1398
+0.0020 (1.45%)
Sep 25, 2026, 5:29 PM CET
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 94.04 million as of September 25, 2026. Its market cap has decreased by -38.80% in one year.
Market Cap
94.04M
Enterprise Value
62.41M
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
ChartMarket Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 94.04M, a decrease of -77.84%. That is a compound annual growth rate of -13.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 94.04M | -38.41% |
| Dec 30, 2025 | 152.70M | 64.79% |
| Dec 30, 2024 | 92.66M | 15.47% |
| Dec 29, 2023 | 80.25M | -86.52% |
| Dec 30, 2022 | 595.21M | -64.93% |
| Dec 30, 2021 | 1.70B | -37.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 151.73B |
| Getinge AB | 66.19B |
| Sectra AB | 53.56B |
| Medicover AB | 39.29B |
| Arcoma AB | 101.88M |
| Vivesto AB | 97.32M |
| Boule Diagnostics AB | 93.20M |
| Biovica International AB | 91.37M |